CYP2D6 phenotypes among Javanese and Sundanese subjects in Indonesia

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Objective: The objective of this study was to determine CYP2D6 phenotype in a Javanese and Sundanese healthy subject in Indonesia. Methods: Ninety unrelated healthy Indonesian subjects from Java and Sunda were studied. Metoprolol was used as phenotyping substrate. A 100 mg oral tablet of metoprolol was administered to all the subjects. Urinary metoprolol and α-hydroxymetoprolol were determined to calculate metoprolol metabolic ratio (MR). Determination of metoprolol and α-hydroxymetoprolol was carried out by high performance liquid chromatography method. Results: Metoprolol MR varied widely (from 0.08 to 72.75). One subject (1.11%) in the study was classified as poor metabolizer (PM), one subject (1.11%) as ultrarapid metabolizer, and the remaining 88 subjects (97.78%) were classified as extensive metabolizers. Conclusion: The frequencies of PM for the CYP2D6 phenotype (1.11%) in the Javanese and Sundanese population are in concordance with most results of oxidation metabolizers in other Asian populations.

Cite

CITATION STYLE

APA

Utami, P. I., Sugiyanto, S., Martono, S., & Hakim, L. (2019). CYP2D6 phenotypes among Javanese and Sundanese subjects in Indonesia. International Journal of Applied Pharmaceutics, 11(Special Issue 5), 36–39. https://doi.org/10.22159/ijap.2019.v11s5.T0038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free